EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Measurement properties and interpretability of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure

Rachael Pattinson iD, Nirohshah Trialonis-Suthakharan iD, Tim Pickles iD, Jennifer Austin iD, Allison FitzGerald, Matthias Augustin iD, Christine Bundy iD

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae267 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Rachael Pattinson und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Healthcare Sciences, Cardiff University, Cardiff, UK. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Skin Diseases, Quality of Life, Psychometrics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: International Alliance of Dermatology Patient Organizations, Global Research on the Impact of Dermatological Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patient-reported outcome measures (PROMs) are crucial in assessing the impact of dermatological conditions on people’s lives, but the existing dermatology-specific PROMs are not recommended for use, according to COSMIN. We developed the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure in partnership with patients. It has strong evidence of content validity, structural validity, internal consistency, acceptability and feasibility.

Objectives

To test the remaining measurement properties of the PRIDD and establish the interpretability of scores against the COSMIN criteria, using classic and modern psychometric methods.

Methods

A global longitudinal study consisting of two online surveys administered 2–4 weeks apart was carried out. Adults (≥ 18 years of age) living with a dermatological condition were recruited via the International Alliance of Dermatology Patient Organizations’ (GlobalSkin) membership network. Participants completed PRIDD, a demographics questionnaire and other related measures, including the Dermatology Life Quality Index. We tested the criterion validity, construct validity and responsiveness (Spearman’s ρ, independent-samples t-tests and Anova); test–retest reliability [interclass correlation coefficient (ICC)]; measurement error [smallest detectable change or limits of agreement (LoA), distribution-based minimally important change (MIC)]; floor and ceiling effects (number of minimum and maximum scores and person–item location distribution maps), score bandings (κ coefficient of agreement) and the anchor-based MIC of the PRIDD.

Results

In total, 504 people with 35 dermatological conditions from 38 countries participated. Criterion validity (ρ = 0.79), construct validity (76% hypotheses met), test–retest validity (ICC = 0.93) and measurement error (LoA = 1.3 < MIC = 4.14) were sufficient. Floor and ceiling effects were in the acceptable range (< 15%). Score bandings were determined (κ = 0.47); however, the anchor-based MIC could not be calculated owing to an insufficient anchor.

Conclusions

PRIDD is a valid and reliable tool to evaluate the impact of dermatological disease on people’s lives in research and clinical practice. It is the first dermatology-specific PROM to meet the COSMIN criteria. These results support the value of developing and validating PROMs with a patient-centred approach and using classic and modern psychometric methods. Further testing of responsiveness and MIC, cross-cultural translation, linguistic validation and global data collection are planned.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient Reported Outcome MeasuresSkin DiseasesQuality of LifePsychometricsHumansMaleFemaleAdultMiddle AgedReproducibility of ResultsLongitudinal StudiesAgedYoung AdultAdolescentSurveys and Questionnaires

Autor:innen und Institutionen

  • School of Healthcare Sciences, Cardiff University, Cardiff, UK.
  • Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Centre for Trials Research, Cardiff University, Cardiff, UK.
  • International Alliance of Dermatology Patient Organizations, Ottawa, Canada.

ORCID-Profile: Rachael Pattinson, Nirohshah Trialonis-Suthakharan, Tim Pickles, Jennifer Austin, Matthias Augustin, Christine Bundy

Förderung

  • International Alliance of Dermatology Patient Organizations
  • Global Research on the Impact of Dermatological Diseases

Zitieren

APA

Pattinson, R., Trialonis-Suthakharan, N., Pickles, T., Austin, J., FitzGerald, A., Augustin, M., & Bundy, C. (2024). Measurement properties and interpretability of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae267

Vancouver

Pattinson R, Trialonis-Suthakharan N, Pickles T, Austin J, FitzGerald A, Augustin M, et al. Measurement properties and interpretability of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae267

BibTeX
@article{Pattinson2024,
  author = {Pattinson, Rachael and Trialonis-Suthakharan, Nirohshah and Pickles, Tim and Austin, Jennifer and FitzGerald, Allison and Augustin, Matthias and Bundy, Christine},
  title = {Measurement properties and interpretability of the Patient-Reported Impact of Dermatological Diseases (PRIDD) measure},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae267}
}
Kostenlos starten →